-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SiXAXuHDQxHDqjlVoVFkgPetTS2ep5mHexvB9pYCAAOQmgDL1JNcRb87KO196j6d E3CAs5gOG8tXqqDY9/ymtA== 0001013762-11-000510.txt : 20110301 0001013762-11-000510.hdr.sgml : 20110301 20110301124303 ACCESSION NUMBER: 0001013762-11-000510 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110223 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20110301 DATE AS OF CHANGE: 20110301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: United Health Products, Inc. CENTRAL INDEX KEY: 0001096938 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 841517723 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-27781 FILM NUMBER: 11650143 BUSINESS ADDRESS: STREET 1: 1365 N. COURTENAY PARKWAY STREET 2: SUITE A CITY: MERRITT ISLAND STATE: FL ZIP: 32953 BUSINESS PHONE: 321-452-9091 MAIL ADDRESS: STREET 1: P.O. BOX 307 CITY: COCOA STATE: FL ZIP: 32923-0307 FORMER COMPANY: FORMER CONFORMED NAME: United EcoEnergy Corp. DATE OF NAME CHANGE: 20060224 FORMER COMPANY: FORMER CONFORMED NAME: MNS EAGLE EQUITY GROUP III INC DATE OF NAME CHANGE: 19991019 8-K 1 form8k.htm UNITED HEALTH PRODUCTS FORM 8-K form8k.htm
UNITED STATES
 
 
SECURITIES AND EXCHANGE COMMISSION
 
 
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
 
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
February 23, 2011
 
 
Date of Report (Date of earliest event reported)
 
UNITED HEALTH PRODUCTS, INC.
 
(Exact name of registrant as specified in its charter)
 
Nevada
814-00717
84-1517723
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

120 Wall Street, 24 th Floor
New York, NY
10005
(Address of principal executive offices)
(Zip Code)
   

646-896-3050
Registrant's telephone number, including area code
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
____ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
____ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
 
____ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
 
____ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
 
 
1
 
Section 5 - Corporate Governance and Management
 
Item 5.02 -  Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
 
On February 23, 2011, Kelly T. Hickel resigned as Chairman. CEO, President and member of our Board of Directors. His resignation was not the result of any disagreement with us on any matter relating to operations, policies or practices, including accounting or financial policies. On this date, the Board of Directors appointed Dr. Phillip Forman as the Chairman, CEO, President and member of the Board of Directors.
 
Phillip Forman, DPM, served as the Co-Chief Compliance Officer of The Center for Wound Healing, Inc. (“CFWH”), a leading manager of comprehensive wound care treatment centers that offer hyperbaric oxygen therapy as well as traditional wound care treatment modalities.  Prior to Dr. Forman’s service with CFWH, he was the Medical Director of the New York Hyperbaric, the predecessor to American Hyperbaric, Inc., since 2001 and, from July, 2005 through January 18, 2007, served as the chief executive officer of American Hyperbaric, Inc.  Prior to joining New York Hyperbaric, Dr. Forman served as the co-medical director of the Staten Island University Hospital diabetic Treatment Center.

Dr. Forman received his doctor degree of Podiatric Medicine from the Pennsylvania College of Podiatric Medicine. His degree is a Diplomat, American Board of Podiatric Surgery. His academic appointments include Podiatric Attending and he has lectured both nationally and internationally on advanced wound care and hyperbaric medicine.  In addition, Dr. Forman has extensively participated in numerous wound care clinical trials involving diabetic foot infections, novel antibiotics, and new biopharmaceuticals for problem and non-healing wounds of the lower extremities.

 
 
 

 
 
 
 
 
 
 
 


 
2
 

 

 
SIGNATURE
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
       
Date: March  1, 2011
By:
/s/ Jan E. Chason  
   
Jan E. Chason
  
   
Chief Financial Officer
  
       

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3
 -----END PRIVACY-ENHANCED MESSAGE-----